Intrasense

Equities

ALINS

FR0011179886

Advanced Medical Equipment & Technology

Market Closed - Euronext Paris Other stock markets 11:35:10 2024-07-15 EDT			5-day change	1st Jan Change
0.277 ^EUR	+2.59%		0.00%	-23.06%

06-10	Intrasense: participation in the SIRM congress in Milan	CF
04-17	Intrasense: an innovative solution for cancer monitoring	CF

Intrasense : Bilan semestriel du contrat de liquidité

January 10, 2023 at 11:54 am

Bilan semestriel du contrat de liquidité

10 Jan 2023 17:45 CET

Issuer

INTRASENSE

prbilan-semestriel-contrat-liquiditejanv-231.pdf

Source

INTRASENSE

Provider

Euronext

Company Name

INTRASENSE

ISIN

FR0011179886

Symbol

ALINS

Market

Euronext Growth

Attachments

Original Link
Original Document
Permalink

Disclaimer

Intrasense SA published this content on 10 January 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 January 2023 16:53:09 UTC.

Latest news about Intrasense

Intrasense: participation in the SIRM congress in Milan	06-10	CF
Intrasense: an innovative solution for cancer monitoring	04-17	CF
Guerbet: CE certificate for a platform	04-09	CF
Intrasense: awarded CE certificate	04-09	CF
Invest Securities Raises Intrasense PT, Maintains Neutral Rating	03-22	MT
INTRASENSE : Invest Securities adjusts its target	03-22	CF
Intrasense S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI
CAC40: gloomy end to the week, timid weekly gain (+0.7%)	02-09	CF
Intrasense: 2023 sales down on China	02-09	CF
Guerbet: sales growth of 4% by 2023	02-09	CF
Intrasense Partners with Software Company EDL for Myrian Distribution	23-10-19	MT
Intrasense S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-14	CI
Invest Securities Downgrades Intrasense to Neutral from Buy	23-08-04	MT
INTRASENSE : Invest Securities downgrades its recommendation	23-08-04	CF
Guerbet wins prostate cancer challenge	23-07-17	CF
Guerbet: agreement on AI for medical imaging	23-06-19	CF
Intrasense: joins Guerbet Group following successful takeover bid	23-06-12	CF
Guerbet: Intrasense joins the group	23-06-12	CF
Guerbet: holds 56.5% of Intrasense following reopening of its offer	23-06-09	CF
Guerbet SA completed the acquisition of 17.82% stake in Intrasense SA.	23-06-04	CI
Global markets live: Micron, Qantas, Zoom, Meta, BT Group...	23-05-23
Guerbet: takeover bid for Intrasense to resume on May 23	23-05-22	CF
Guerbet: successful takeover bid for Intrasense	23-05-22	CF
Guerbet: takeover bid opened for Intrasense shares	23-04-06	CF
Guerbet: AMF gives the green light to the takeover bid for Intrasense	23-04-05	CF

Chart Intrasense

Duration

Period

More charts

Company Profile

Founded in 2004, Intrasense develops and markets a unique medical device named Myrian®, a software platform facilitating and ensuring diagnosis, decision-making and therapeutic follow-up. Thanks to Myrian®, more than 1,200 hospitals and clinics spread over 40 countries use a unique and integrated platform supporting all types of imaging modalities (MRI, scanner...). Enriched with expert clinical modules dedicated to specific pathologies and organs, Myrian® provides a universal medical image processing solution which can be fully integrated into any healthcare information system.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-09-24 - Q2 2024 Earnings Release

More about the company

Income Statement Evolution

More financial data

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
INTRASENSE	-23.06%	15.83M
THERMO FISHER SCIENTIFIC	+2.62%	208B
DANAHER CORPORATION	+6.44%	182B
INTUITIVE SURGICAL, INC.	+29.61%	155B
BOSTON SCIENTIFIC CORPORATION	+34.96%	115B
SIEMENS HEALTHINEERS AG	+3.84%	66.52B
EDWARDS LIFESCIENCES CORPORATION	+17.38%	53.93B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	-4.51%	46.26B
AGILENT TECHNOLOGIES, INC.	-5.77%	38.22B
GE HEALTHCARE TECHNOLOGIES INC.	+3.71%	36.6B

Other Advanced Medical Equipment & Technology